Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
J Nephrol. 2012 Jan 16:0. doi: 10.5301/jn.5000069. [Epub ahead of print]
Related citations
Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA.
J Nephrol. 2011 Sep 23:0. doi: 10.5301/jn.5000030. [Epub ahead of print]
Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV.
Cui JH, Qiao Q, Guo Y, Zhang YQ, Cheng H, He FR, Zhang J.
J Nephrol. 2012 Mar-Apr;25(2):255-61. doi: 10.5301/JN.2011.8451.
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.
Roccatello D, Rossi D, Marletto F, Naretto C, Sciascia S, Baldovino S, Piras D, Giachino O.
J Nephrol. 2012 Mar-Apr;25(2):198-203. doi: 10.5301/JN.2011.8452.
Choroidopathy in patients with systemic lupus erythematosus with or without nephropathy.
Baglio V, Gharbiya M, Balacco-Gabrieli C, Mascaro T, Gangemi C, Di Franco M, Pistolesi V, Morabito S, Pecci G, Pierucci A.
J Nephrol. 2011 Jul-Aug;24(4):522-9. doi: 10.5301/JN.2011.6244.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on